|
2018
|
Invention
|
Novel antibody useful in neurological or neurodegenerative disorders.
The present invention rela... |
|
2014
|
Invention
|
Novel antibody useful in neurological or neurodegenerative disorders. The present invention relat... |
|
2012
|
Invention
|
Treatment of neurological or neurodegenerative disorders.
The invention relates to a protein or ... |
|
2010
|
Invention
|
Treatment of coagulopathy with hyperfibrinolysis.
The present invention relates to the use of th... |
|
|
Invention
|
Treatment of coagulopathy with hyperfibrinolysis. The present invention relates to the use of thr... |
|
|
Invention
|
Treatment of neurological of neurodegenerative disorder. Use of a protein or peptide for the manu... |
|
|
Invention
|
Treatment of neurological or neurodegenerative disorders. The Invention relates to a protein or p... |
|
2009
|
Invention
|
Boronic acid salts.
Salts of a peptide boronic acid drug, for example of Cbz-(R)-Phe-(S)-Pro-(R)... |
|
|
Invention
|
Peptide boronic acid inhibitors.
A pharmaceutically acceptable base addition salt of an organobo... |
|
|
Invention
|
Multivalent metal salts of boronic acids.
Salts of a pharmaceutically acceptable divalent metal ... |
|
2008
|
Invention
|
Novel patient subgroups for thrombolysis. A method for treating a stroke patient with thrombolysi... |
|
|
Invention
|
Prevention and treatment of radiation injury.
The invention relates to the field of radiation in... |
|
|
Invention
|
Prevention and treatment of radiation injury. The invention relates to the field of radiation inj... |
|
|
Invention
|
Treatment of inflammatory bowel disease. Use of thrombomodulin or thrombomodulin analogues for th... |
|
|
Invention
|
Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction. Use of thromb... |
|
|
Invention
|
Boronic acid salts useful in parenteral formulations.
Salts of a peptide boronic acid drug, for ... |
|
2007
|
Invention
|
Boronic acid salts.
Salts of a peptide boronic add drug, for example of Cbz-(R)-Phe-(S)-Pro-(R)-... |
|
|
Invention
|
Method for the manufacture of a medicament for treating hemorrhagic stroke. Use of a plasminogen ... |
|
2006
|
Invention
|
Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism. Use of... |
|
2005
|
Invention
|
Non-neurotoxic plasminogen activating factors for treating of stroke.
The invention pertains to ... |
|
|
Invention
|
Targeted plasminogen activator fusion proteins as thrombolytic agents. This invention relates to ... |
|
|
G/S
|
Medicines namely pharmaceutical preparations for the treatment of thrombotic and haemostatic diso... |
|
|
G/S
|
Pharmaceutical preparations for health care, namely pharmaceutical preparations for the treatment... |
|
|
G/S
|
Chemical reagents for research purposes; biochemical
preparations for scientific purposes. Pharm... |
|
|
Invention
|
Peptide boronic acid compounds useful in anticoagulation.
A method for preventing thrombosis in ... |
|
2004
|
G/S
|
Pharmaceutical, biochemical, biotechnological and veterinary preparations, sanitary preparations,... |
|
|
Invention
|
Plasminogen activators having a reduced capacity to bind lysine. The invention relates to the use... |
|
|
Invention
|
Plasminogen activators having reduced lysine binding capacity. The invention relates to the use o... |
|
|
Invention
|
Peptide boronic acids useful in making salts thereof.
Tripeptide boronic acids of (R,S,R) config... |
|
|
Invention
|
Methods for synthesizing organoboronic compounds and products thereof.
Organoboronic acids, for ... |
|
|
Invention
|
Production of mammalian proteins in plant cells. A method for producing Solulin or DSPA&agr;l is ... |
|
|
Invention
|
Glutamate receptor antagonists as neuroprotectives.
The invention relates to the use of inhibiti... |
|
|
Invention
|
Glutamate receptor antagonists as neuroprotectives. The invention relates to the use of an inhibi... |
|
|
Invention
|
Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke. The ... |
|
2003
|
Invention
|
Multivalent metal salts of boronic acids. Salts of a pharmaceutically acceptable divalent metal a... |
|
|
Invention
|
Boronic acid salts useful in parenteral formulations. 2. The counter-ion to the boronate may be a... |
|
2002
|
Invention
|
Non-neurotoxic plasminogen activating factors for treating stroke.
The invention concerns the us... |
